Aziz-Ur Rehman
Director Financiero/CFO en GOLDEN AGE EXPLORATION LTD. .
Perfil
Aziz-Ur Rehman is currently working as a Controller at KOP Therapeutics Corp.
since 2021 and as the Chief Financial Officer & Secretary at Golden Age Exploration Ltd.
since 2022.
Previously, he worked as the Chief Financial Officer & Director at AEL Textiles Ltd.
and as an Accountant at Hampsom Equities Ltd.
from 2016 to 2019.
Mr. Rehman completed his undergraduate degree at Athabasca University.
Cargos activos de Aziz-Ur Rehman
Empresas | Cargo | Inicio |
---|---|---|
GOLDEN AGE EXPLORATION LTD. | Director Financiero/CFO | 11/01/2022 |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | Comptroller/Controller/Auditor | 01/02/2021 |
Antiguos cargos conocidos de Aziz-Ur Rehman.
Empresas | Cargo | Fin |
---|---|---|
Hampsom Equities Ltd. | Comptroller/Controller/Auditor | 01/03/2019 |
AEL TEXTILES LIMITED | Director Financiero/CFO | - |
Formación de Aziz-Ur Rehman.
Athabasca University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
GOLDEN AGE EXPLORATION LTD. | Non-Energy Minerals |
Empresas privadas | 3 |
---|---|
AEL Textiles Ltd.
AEL Textiles Ltd. Alternative Power GenerationUtilities AEL Textiles Ltd. engages in dealing and trading of textile products and materials. The company was founded on February 20, 1994 and is headquartered in Lahore, Pakistan. | Utilities |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | Health Technology |
Hampsom Equities Ltd. |
- Bolsa de valores
- Insiders
- Aziz-Ur Rehman